Novartis AG (NVS): Price and Financial Metrics


Novartis AG (NVS): $88.65

0.97 (+1.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NVS POWR Grades


  • Stability is the dimension where NVS ranks best; there it ranks ahead of 97.93% of US stocks.
  • NVS's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • NVS ranks lowest in Momentum; there it ranks in the 8th percentile.

NVS Stock Summary

  • NVS has a market capitalization of $195,579,594,849 -- more than approximately 98.87% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Novartis Ag is reporting a growth rate of 150.75%; that's higher than 86.77% of US stocks.
  • In terms of volatility of its share price, NVS is more volatile than only 8.5% of stocks we're observing.
  • Stocks that are quantitatively similar to NVS, based on their financial statements, market capitalization, and price volatility, are BMY, NFLX, NVO, AMGN, and MRK.
  • NVS's SEC filings can be seen here. And to visit Novartis Ag's official web site, go to www.novartis.com.

NVS Valuation Summary

  • In comparison to the median Healthcare stock, NVS's price/sales ratio is 5.26% higher, now standing at 4.
  • NVS's price/sales ratio has moved down 0.7 over the prior 243 months.
  • Over the past 243 months, NVS's EV/EBIT ratio has gone up 1.9.

Below are key valuation metrics over time for NVS.

Stock Date P/S P/B P/E EV/EBIT
NVS 2021-08-31 4 3.8 23.0 20.2
NVS 2021-08-30 4 3.8 22.8 20.1
NVS 2021-08-27 4 3.8 22.9 20.2
NVS 2021-08-26 4 3.8 22.8 20.1
NVS 2021-08-25 4 3.8 22.9 20.1
NVS 2021-08-24 4 3.8 22.9 20.2

NVS Growth Metrics

    Its 4 year price growth rate is now at 15.42%.
  • The 5 year net income to common stockholders growth rate now stands at 78.85%.
  • Its 5 year cash and equivalents growth rate is now at -10.97%.
Over the past 70 months, NVS's revenue has gone up $2,882,000,000.

The table below shows NVS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 52,877 15,071 24,021
2021-09-30 52,385 15,192 9,807
2021-06-30 51,556 13,423 8,984
2021-03-31 49,884 13,252 7,955
2020-12-31 49,898 13,650 8,072
2020-09-30 49,584 13,185 7,103

NVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NVS has a Quality Grade of B, ranking ahead of 86.01% of graded US stocks.
  • NVS's asset turnover comes in at 0.42 -- ranking 108th of 682 Pharmaceutical Products stocks.
  • GHSI, KALA, and ADAP are the stocks whose asset turnover ratios are most correlated with NVS.

The table below shows NVS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.420 0.693 0.212
2021-06-30 0.406 0.691 0.194
2021-03-31 0.393 0.691 0.176
2020-12-31 0.392 0.697 0.182
2020-09-30 0.401 0.700 0.174
2020-06-30 0.412 0.699 0.180

NVS Stock Price Chart Interactive Chart >

Price chart for NVS

NVS Price/Volume Stats

Current price $88.65 52-week high $95.17
Prev. close $87.68 52-week low $79.09
Day low $88.01 Volume 3,820,100
Day high $89.08 Avg. volume 2,656,720
50-day MA $87.90 Dividend yield 2.46%
200-day MA $86.29 Market Cap 198.29B

Novartis AG (NVS) Company Bio


Novartis AG offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines. The company was founded in 1895 and is based in Basel, Switzerland.


NVS Latest News Stream


Event/Time News Detail
Loading, please wait...

NVS Latest Social Stream


Loading social stream, please wait...

View Full NVS Social Stream

Latest NVS News From Around the Web

Below are the latest news stories about Novartis Ag that investors may wish to consider to help them evaluate NVS as an investment opportunity.

Excellent growth of Anti Epileptic Drugs market examined in new market research report 2022-2029- Top Key Players- Novartis AG, GlaxoSmithKline Plc, Johnson & Johnson Service Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc.

The global Global Anti Epileptic Drugs market has been deliberately studied in the report with a large focus on the top players and business strategies, geological expansion, market sections, serious scenes, assembly and estimation, and cost structures. Each segment of

OpenPR | February 24, 2022

Alzheimer''s Drugs Market Forecast to Grow at Steady Pace During 2022-2028 | Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG

Coherent Market Insights has announced new analysis on Alzheimer''s Drugs Market Status 2022-2028 which has been prepared based on an in-depth market analysis with inputs from industry experts and top vendors in the business. The report covers the market landscape

OpenPR | February 24, 2022

The Zacks Analyst Blog Highlights NVIDIA, Novartis AG, NextEra Energy, The Goldman Sachs Group and Amgen

NVIDIA, Novartis AG, NextEra Energy, The Goldman Sachs Group and Amgen are included in this blog.

Yahoo | February 23, 2022

Vontobel: Angespannte Börsen - defensive BRC im Fokus

Callable Multi Barrier Reverse Convertible auf Nestlé, Novartis, Roche / Holcim, Nestlé, Swatch, UBS Group, Zurich Insurance / ABB , Geberit, Holcim, OC Oerlikon, Sika / Adecco, Nestlé, Roche, Swisscom, Zurich Insurance

Cash | February 22, 2022

Top Stock Reports for NVIDIA, Novartis & NextEra Energy

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Novartis AG (NVS), and NextEra Energy, Inc. (NEE).

Yahoo | February 22, 2022

Read More 'NVS' Stories Here

NVS Price Returns

1-mo -2.84%
3-mo 5.34%
6-mo 11.44%
1-year 3.48%
3-year 15.82%
5-year 42.71%
YTD 4.04%
2021 -5.12%
2020 2.08%
2019 28.03%
2018 5.95%
2017 18.80%

NVS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full NVS Dividend History

Continue Researching NVS

Want to see what other sources are saying about Novartis Ag's financials and stock price? Try the links below:

Novartis Ag (NVS) Stock Price | Nasdaq
Novartis Ag (NVS) Stock Quote, History and News - Yahoo Finance
Novartis Ag (NVS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9029 seconds.